{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:50:15Z","timestamp":1789840215290,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["99-2-410-49563"],"award-info":[{"award-number":["99-2-410-49563"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-023-09106-9","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T17:02:15Z","timestamp":1706806935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The obeticholic acid can positively regulate the cancerous behavior of MCF7 breast cancer cell line"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3789-0329","authenticated-orcid":false,"given":"Reza","family":"Rahmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7515-5862","authenticated-orcid":false,"given":"Neda","family":"Eivazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9949-5773","authenticated-orcid":false,"given":"Solaleh","family":"Emamgholipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3997-6954","authenticated-orcid":false,"given":"Mahdi","family":"Aminian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0849-4506","authenticated-orcid":false,"given":"Ali","family":"Jalilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8050-2534","authenticated-orcid":false,"given":"Maliheh","family":"Paknejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"9106_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S (2022) Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 66:15\u201323. https:\/\/doi.org\/10.1016\/j.breast.2022.08.010","journal-title":"Breast"},{"key":"9106_CR2","doi-asserted-by":"publisher","DOI":"10.4103\/pm.pm_540_21","author":"H Shi","year":"2022","unstructured":"Shi H, Ji H, Zhu F, Zhao Y, Yin Y, Shu F, Wang L (2022) Antitumor potential of peptides isolated from brucea javanica globulin fraction on MCF-7 cells. Pharmacogn Mag. https:\/\/doi.org\/10.4103\/pm.pm_540_21","journal-title":"Pharmacogn Mag"},{"key":"9106_CR3","doi-asserted-by":"publisher","first-page":"111262","DOI":"10.1016\/j.mce.2021.111262","volume":"528","author":"J Wu","year":"2021","unstructured":"Wu J, Nagy LE, Wang L (2021) The long and the small collide: LncRNAs and small heterodimer partner (SHP) in liver disease. Mol Cell Endocrinol 528:111262","journal-title":"Mol Cell Endocrinol"},{"issue":"S1","key":"9106_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.00657","volume":"34","author":"J Nguyen","year":"2020","unstructured":"Nguyen J, Riessen R, Rodriguez-Otero J, Anakk S (2020) Investigating the intestine-specific role of small heterodimer partner. FASEB J 34(S1):1\u20131. https:\/\/doi.org\/10.1096\/fasebj.2020.34.s1.00657","journal-title":"FASEB J"},{"key":"9106_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175808","author":"S Chen","year":"2023","unstructured":"Chen S, Sun S, Feng Y, Li X, Yin G, Liang P, Yu W, Meng D, Zhang X, Liu H (2023) Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C\/PPAR\u03b1\/CD36 pathway. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175808","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"9106_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.14348\/molcells.2020.0041","volume":"43","author":"YJ Lee","year":"2020","unstructured":"Lee YJ, Lee E-Y, Choi BH, Jang H, Myung J-K, You HJ (2020) The role of nuclear receptor subfamily 1 group H member 4 (NR1H4) in colon cancer cell survival through the regulation of c-Myc stability. Mol Cells 43(5):459\u2013468. https:\/\/doi.org\/10.14348\/molcells.2020.0041","journal-title":"Mol Cells"},{"issue":"2","key":"9106_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.canlet.2015.10.031","volume":"370","author":"N Alasmael","year":"2016","unstructured":"Alasmael N, Mohan R, Meira LB, Swales KE, Plant NJ (2016) Activation of the farnesoid X-receptor in breast cancer cell lines results in cytotoxicity but not increased migration potential. Cancer Lett 370(2):250\u2013259. https:\/\/doi.org\/10.1016\/j.canlet.2015.10.031","journal-title":"Cancer Lett"},{"key":"9106_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02819-w","author":"J Yu","year":"2020","unstructured":"Yu J, Li S, Guo J, Xu Z, Zheng J, Sun X (2020) Farnesoid X receptor antagonizes Wnt\/\u03b2-catenin signaling in colorectal tumorigenesis. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-020-02819-w","journal-title":"Cell Death Dis"},{"issue":"9","key":"9106_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23095259","volume":"23","author":"C-R Lai","year":"2022","unstructured":"Lai C-R, Wang H-H, Chang H-H, Tsai Y-L, Tsai W-C, Lee C-R, Changchien C-Y, Cheng Y-C, Wu S-TC (2022) Enhancement of farnesoid X receptor inhibits migration, adhesion and angiogenesis through proteasome degradation and VEGF reduction in bladder cancers. Int J Mol Sci 23(9):5259. https:\/\/doi.org\/10.3390\/ijms23095259","journal-title":"Int J Mol Sci"},{"key":"9106_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/164_2019_238","author":"S Fiorucci","year":"2019","unstructured":"Fiorucci S, Distrutti E (2019) The pharmacology of bile acids and their receptors. Bile Acids Recept. https:\/\/doi.org\/10.1007\/164_2019_238","journal-title":"Bile Acids Recept"},{"issue":"11","key":"9106_CR11","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2174\/0929867324666170124151940","volume":"24","author":"D Moris","year":"2017","unstructured":"Moris D, Giaginis C, Tsourouflis G, Theocharis S (2017) Farnesoid-X receptor (FXR) as a promising pharmaceutical target in atherosclerosis. Curr Med Chem 24(11):1147\u20131157. https:\/\/doi.org\/10.2174\/0929867324666170124151940","journal-title":"Curr Med Chem"},{"issue":"10","key":"9106_CR12","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1080\/17460441.2021.1916465","volume":"16","author":"S Fiorucci","year":"2021","unstructured":"Fiorucci S, Biagioli M, Baldoni M, Ricci P, Sepe V, Zampella A, Distrutti E (2021) The identification of farnesoid X receptor modulators as treatment options for nonalcoholic fatty liver disease. Expert Opin Drug Discov 16(10):1193\u20131208. https:\/\/doi.org\/10.1080\/17460441.2021.1916465","journal-title":"Expert Opin Drug Discov"},{"key":"9106_CR13","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1016\/j.csbj.2021.04.029","volume":"19","author":"L Jiang","year":"2021","unstructured":"Jiang L, Zhang H, Xiao D, Wei H, Chen Y (2021) Farnesoid X receptor (FXR): structures and ligands. Comput Struct Biotechnol J 19:2148\u20132159. https:\/\/doi.org\/10.1016\/j.csbj.2021.04.029","journal-title":"Comput Struct Biotechnol J"},{"key":"9106_CR14","doi-asserted-by":"publisher","first-page":"1152042","DOI":"10.3389\/fphar.2023.1152042","volume":"14","author":"Z Yang","year":"2023","unstructured":"Yang Z, Wang L (2023) Current, emerging, and potential therapies for non-alcoholic steatohepatitis. Front Pharmacol 14:1152042. https:\/\/doi.org\/10.3389\/fphar.2023.1152042","journal-title":"Front Pharmacol"},{"issue":"10","key":"9106_CR15","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.3390\/biomedicines10102464","volume":"10","author":"A Floreani","year":"2022","unstructured":"Floreani A, Gabbia D, De Martin S (2022) Obeticholic acid for primary biliary cholangitis. Biomedicines 10(10):2464. https:\/\/doi.org\/10.3390\/biomedicines10102464","journal-title":"Biomedicines"},{"issue":"2","key":"9106_CR16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3322\/caac.21706","volume":"72","author":"JJ Mao","year":"2022","unstructured":"Mao JJ, Pillai GG, Andrade CJ, Ligibel JA, Basu P, Cohen L, Khan IA, Mustian KM, Puthiyedath R, Dhiman KS (2022) Integrative oncology: addressing the global challenges of cancer prevention and treatment. CA: Cancer J Clin 72(2):144\u2013164. https:\/\/doi.org\/10.3322\/caac.21706","journal-title":"CA: Cancer J Clin"},{"key":"9106_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/rpsppr\/rqac001","author":"TS Aishwarya","year":"2022","unstructured":"Aishwarya TS, Mounika N, Vishwakarma G, Adela R (2022) Effect of obeticholic acid in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) patients: a systematic review and meta-analysis. RPS Pharm Pharmacol Rep. https:\/\/doi.org\/10.1093\/rpsppr\/rqac001","journal-title":"RPS Pharm Pharmacol Rep"},{"key":"9106_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021668","author":"VS Atanasova","year":"2023","unstructured":"Atanasova VS, Riedl A, Strobl M, Flandorfer J, Unterleuthner D, Weindorfer C, Neuhold P, Stang S, Hengstschl\u00e4ger M, Bergmann M (2023) Selective eradication of colon cancer cells harboring PI3K and\/or MAPK pathway mutations in 3D culture by combined PI3K\/AKT\/mTOR pathway and MEK inhibition. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24021668","journal-title":"Int J Mol Sci"},{"key":"9106_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.biocel.2019.05.004","volume":"112","author":"G Amable","year":"2019","unstructured":"Amable G, Mart\u00ednez-Le\u00f3n E, Picco ME, Di Siervi N, Davio C, Rozengurt E, Rey O (2019) Metformin inhibits \u03b2-catenin phosphorylation on Ser-552 through an AMPK\/PI3K\/Akt pathway in colorectal cancer cells. Int J Biochem Cell Biol 112:88\u201394. https:\/\/doi.org\/10.1016\/j.biocel.2019.05.004","journal-title":"Int J Biochem Cell Biol"},{"key":"9106_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153465","volume":"82","author":"X Fan","year":"2021","unstructured":"Fan X, Xie M, Zhao F, Li J, Fan C, Zheng H, Wei Z, Ci X, Zhang S (2021) Daphnetin triggers ROS-induced cell death and induces cytoprotective autophagy by modulating the AMPK\/Akt\/mTOR pathway in ovarian cancer. Phytomedicine 82:153465. https:\/\/doi.org\/10.1016\/j.phymed.2021.153465","journal-title":"Phytomedicine"},{"issue":"1","key":"9106_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2020.11725","volume":"23","author":"Y-H Chen","year":"2021","unstructured":"Chen Y-H, Yang S-F, Yang C-K, Tsai H-D, Chen T-H, Chou M-CH (2021) Metformin induces apoptosis and inhibits migration by activating the AMPK\/p53 axis and suppressing PI3K\/AKT signaling in human cervical cancer cells. Mol Med Rep 23(1):1\u20131. https:\/\/doi.org\/10.3892\/mmr.2020.11725","journal-title":"Mol Med Rep"},{"issue":"10","key":"9106_CR22","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/j.yexcr.2018.01.036","volume":"13","author":"J-B Xiao","year":"2020","unstructured":"Xiao J-B, Ma J-Q, Yakefu K, Tursun M (2020) Effect of the SIRT3-AMPK\/PPAR pathway on invasion and migration of cervical cancer cells. Int J Clin Exp Pathol 13(10):2495. https:\/\/doi.org\/10.1016\/j.yexcr.2018.01.036","journal-title":"Int J Clin Exp Pathol"},{"key":"9106_CR23","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1260502\/v1","author":"T Yaguchi","year":"2022","unstructured":"Yaguchi T, Taira H, Kameno M, Kawakami J (2022) Mitochondrial dynamics of Bcl-2 family during E2-induced apoptosis correlates with the malignant of endometrial. Journal Cancer Cells. https:\/\/doi.org\/10.21203\/rs.3.rs-1260502\/v1","journal-title":"Journal Cancer Cells"},{"issue":"1","key":"9106_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13578-023-01104-5","volume":"13","author":"D Qin","year":"2023","unstructured":"Qin D, Wang R, Ji J, Wang D, Lu Y, Cao S, Chen Y, Wang L, Chen X, Zhang L (2023) Hepatocyte-specific Sox9 knockout ameliorates acute liver injury by suppressing SHP signaling and improving mitochondrial function. Cell Biosci 13(1):159. https:\/\/doi.org\/10.1186\/s13578-023-01104-5","journal-title":"Cell Biosci"},{"issue":"7","key":"9106_CR25","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1080\/08941939.2022.2080308","volume":"35","author":"K Ozdemir","year":"2022","unstructured":"Ozdemir K, Zengin I, Guney Eskiler G, Kocer HB, Ozkan AD, Demiray T, Sahin EO (2022) The predictive role of MMP-2, MMP-9, TIMP-1 and TIMP-2 serum levels in the complete response of the tumor to chemotherapy in breast cancer patients. J Invest Surg 35(7):1544\u20131550. https:\/\/doi.org\/10.1080\/08941939.2022.2080308","journal-title":"J Invest Surg"},{"issue":"17","key":"9106_CR26","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.3390\/molecules26175309","volume":"26","author":"HW Jung","year":"2021","unstructured":"Jung HW, Hwang JH (2021) Anticancer effects of Ursi Fel extract and its active compound, ursodeoxycholic acid, in FRO anaplastic thyroid cancer cells. Molecules 26(17):5309. https:\/\/doi.org\/10.3390\/molecules26175309","journal-title":"Molecules"},{"issue":"12","key":"9106_CR27","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1080\/00365520701452209","volume":"42","author":"G Burnat","year":"2007","unstructured":"Burnat G, Rau T, Elshimi E, Hahn EG, Konturek PC (2007) Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett\u2019s esophageal mucosa and adenocarcinoma cell line. Scand J Gastroenterol 42(12):1460\u20131465. https:\/\/doi.org\/10.1080\/00365520701452209","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"9106_CR28","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/00365520701452209","volume":"119","author":"T Soma","year":"2006","unstructured":"Soma T, Kaganoi J, Kawabe A, Kondo K, Tsunoda S, Imamura M, Shimada Y (2006) Chenodeoxycholic acid stimulates the progression of human esophageal cancer cells: a possible mechanism of angiogenesis in patients with esophageal cancer. Int J Cancer 119(4):771\u2013782. https:\/\/doi.org\/10.1080\/00365520701452209","journal-title":"Int J Cancer"},{"key":"9106_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s13402-017-0353-5","volume":"41","author":"TH Luu","year":"2018","unstructured":"Luu TH, Bard J-M, Carbonnelle D, Chaillou C, Huvelin J-M, Bobin-Dubigeon C, Nazih H (2018) Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells. Cell Oncol 41:13\u201324. https:\/\/doi.org\/10.1007\/s13402-017-0353-5","journal-title":"Cell Oncol"},{"issue":"3","key":"9106_CR30","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.3892\/ol.2016.4842","volume":"12","author":"GY Park","year":"2016","unstructured":"Park GY, Han YK, Han JY, Lee CG (2016) Tauroursodeoxycholic acid reduces the invasion of MDA-MB-231 cells by modulating matrix metalloproteinases 7 and 13. Oncol Lett 12(3):2227\u20132231. https:\/\/doi.org\/10.3892\/ol.2016.4842","journal-title":"Oncol Lett"},{"key":"9106_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.canlet.2018.08.026","volume":"437","author":"I Barone","year":"2018","unstructured":"Barone I, Vircillo V, Giordano C, Gelsomino L, Gy\u0151rffy B, Tarallo R, Rinaldi A, Bruno G, Caruso A, Romeo F (2018) Activation of farnesoid X receptor impairs the tumor-promoting function of breast cancer-associated fibroblasts. Cancer Lett 437:89\u201399. https:\/\/doi.org\/10.1016\/j.canlet.2018.08.026","journal-title":"Cancer Lett"},{"issue":"1","key":"9106_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep21782","volume":"6","author":"C Giordano","year":"2016","unstructured":"Giordano C, Barone I, Vircillo V, Panza S, Malivindi R, Gelsomino L, Pellegrino M, Rago V, Mauro L, Lanzino M (2016) Activated FXR inhibits leptin signaling and counteracts tumor-promoting activities of cancer-associated fibroblasts in breast malignancy. Sci Rep 6(1):1\u201313. https:\/\/doi.org\/10.1038\/srep21782","journal-title":"Sci Rep"},{"key":"9106_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2023.11.011","author":"W Lun","year":"2023","unstructured":"Lun W, Yan Q, Guo X, Zhou M, Bai Y, He J, Cao H, Che Q, Guo J, Su Z (2023) Mechanism of action of the bile acid receptor TGR5 in obesity. Acta Pharm Sin B. https:\/\/doi.org\/10.1016\/j.apsb.2023.11.011","journal-title":"Acta Pharm Sin B"},{"issue":"35","key":"9106_CR34","doi-asserted-by":"publisher","first-page":"31441","DOI":"10.1074\/jbc.M200474200","volume":"277","author":"J Yu","year":"2002","unstructured":"Yu J, Lo J-L, Huang L, Zhao A, Metzger E, Adams A, Meinke PT, Wright SD, Cui J (2002) Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. J Biol Chem 277(35):31441\u201331447. https:\/\/doi.org\/10.1074\/jbc.M200474200","journal-title":"J Biol Chem"},{"key":"9106_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13672","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Gao X, Gao S, Liu Y, Wang W, Feng Y, Pei L, Sun Z, Liu L, Wang C (2023) Effect of gut flora mediated-bile acid metabolism on intestinal immune microenvironment. Immunology. https:\/\/doi.org\/10.1111\/imm.13672","journal-title":"Immunology"},{"key":"9106_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43556-021-00035-2","volume":"2","author":"S Girisa","year":"2021","unstructured":"Girisa S, Henamayee S, Parama D, Rana V, Dutta U, Kunnumakkara AB (2021) Targeting farnesoid X receptor (FXR) for developing novel therapeutics against cancer. Mol Biomed 2:1\u201323. https:\/\/doi.org\/10.1186\/s43556-021-00035-2","journal-title":"Mol Biomed"},{"key":"9106_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000005","author":"CH Ng","year":"2023","unstructured":"Ng CH, Tang ASP, Xiao J, Wong ZY, Yong JN, Fu CE, Zeng RW, Tan C, Wong GHZ, Teng M (2023) Safety and tolerability of obeticholic acid in chronic liver disease: a pooled analysis of 1878 individuals. Hepatol Commun. https:\/\/doi.org\/10.1097\/HC9.0000000000000005","journal-title":"Hepatol Commun"},{"key":"9106_CR38","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s40265-016-0616-x","volume":"76","author":"A Markham","year":"2016","unstructured":"Markham A, Keam SJ (2016) Obeticholic acid: first global approval. Drugs 76:1221\u20131226. https:\/\/doi.org\/10.1007\/s40265-016-0616-x","journal-title":"Drugs"},{"issue":"4","key":"9106_CR39","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.12968\/gasn.2021.19.Sup4.S1","volume":"19","author":"SN Abbas","year":"2021","unstructured":"Abbas SN, Jones D, Kallis Y, Maher L, Patanwala I (2021) Primary biliary cholangitis: assessment and management strategies. Gastrointest Nurs 19(4):S1\u2013S24","journal-title":"Gastrointest Nurs"},{"key":"9106_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/med.21991","author":"K Wang","year":"2023","unstructured":"Wang K, Zhang Y, Wang G, Hao H, Wang H (2023) FXR agonists for MASH therapy: lessons and perspectives from obeticholic acid. Med Res Rev. https:\/\/doi.org\/10.1002\/med.21991","journal-title":"Med Res Rev"},{"key":"9106_CR41","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.123.001557","author":"JA Meshanni","year":"2023","unstructured":"Meshanni JA, Lee JM, Vayas KN, Sun R, Jiang C, Guo GL, Gow AJ, Laskin JD, Laskin DL (2023) Suppression of lung oxidative stress, inflammation and fibrosis following nitrogen mustard exposure by the selective farnesoid X receptor agonist obeticholic acid. J Pharmacol Exp Ther. https:\/\/doi.org\/10.1124\/jpet.123.001557","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-09106-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-09106-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-09106-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T20:20:49Z","timestamp":1738700449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-09106-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9106"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-09106-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]},"assertion":[{"value":"10 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Tehran University of Medical Sciences Research Ethics Committee has confirmed that no ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"250"}}